• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up1.64% Nasdaq Up1.86%

    Regulus Therapeutics Inc. (RGLS)

    -NasdaqGM
    2.87 Up 0.33(12.99%) Jun 29, 4:00PM EDT
    |After Hours : 2.86 Down 0.01 (0.35%) Jun 29, 5:55PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue 20,759   7,669   19,569  
    Cost of Revenue -   -   -  
    Gross Profit 20,759   7,669   19,569  
    Operating Expenses
    Research Development56,387  41,046  29,942  
    Selling General and Administrative19,130  11,533  7,429  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (54,758) (44,910) (17,802)
    Income from Continuing Operations
    Total Other Income/Expenses Net(956)(11,730)(853)
    Earnings Before Interest And Taxes(55,714)(56,640)(18,655)
    Interest Expense52  39  36  
    Income Before Tax(55,766)(56,679)(18,691)
    Income Tax Expense(18)1  (23)
    Minority Interest -   -   -  
    Net Income From Continuing Ops(55,748)(56,680)(18,668)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (55,748) (56,680) (18,668)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (55,748) (56,680) (18,668)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.